Literature DB >> 27305645

Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2.

Mehdi Farshchian1,2, Liisa Nissinen1,2, Reidar Grénman3, Veli-Matti Kähäri1,2.   

Abstract

Entities:  

Keywords:  zzm321990ERKzzm321990; EphB2; apoptosis; dasatinib; squamous cell carcinoma

Mesh：

Substances：

Year:  2016        PMID： 27305645     DOI： 10.1111/exd.13109

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


× No keyword cloud information.
  10 in total

Review 1.  Investigating Cutaneous Squamous Cell Carcinoma in vitro and in vivo: Novel 3D Tools and Animal Models.

Authors:  Marika Quadri; Alessandra Marconi; Simran K Sandhu; Alexi Kiss; Tatiana Efimova; Elisabetta Palazzo
Journal:  Front Med (Lausanne)       Date:  2022-05-09

2.  Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.

Authors:  Mehdi Farshchian; Liisa Nissinen; Elina Siljamäki; Pilvi Riihilä; Minna Piipponen; Atte Kivisaari; Markku Kallajoki; Reidar Grénman; Juha Peltonen; Sirkku Peltonen; Koen D Quint; Jan Nico Bouwes Bavinck; Veli-Matti Kähäri
Journal:  Oncotarget       Date:  2017-07-11

3.  A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study.

Authors:  Alberto Ocana; Marta Gil-Martin; Miguel Martín; Federico Rojo; Silvia Antolín; Ángel Guerrero; José Manuel Trigo; Montse Muñoz; Atanasio Pandiella; Núria Gonzalo Diego; Susana Bezares; Rosalía Caballero; Eva Carrasco; Ander Urruticoechea
Journal:  Oncotarget       Date:  2017-04-14

4.  Long non-coding RNA PICSAR decreases adhesion and promotes migration of squamous carcinoma cells by downregulating α2β1 and α5β1 integrin expression.

Authors:  Minna Piipponen; Jyrki Heino; Veli-Matti Kähäri; Liisa Nissinen
Journal:  Biol Open       Date:  2018-11-14       Impact factor: 2.422

5.  Tumour-cell-derived complement components C1r and C1s promote growth of cutaneous squamous cell carcinoma.

Authors:  P Riihilä; K Viiklepp; L Nissinen; M Farshchian; M Kallajoki; A Kivisaari; S Meri; J Peltonen; S Peltonen; V-M Kähäri
Journal:  Br J Dermatol       Date:  2019-07-28       Impact factor: 9.302

Review 6.  The Roles of EphB2 in Cancer.

Authors:  Wei Liu; Chengpeng Yu; Jianfeng Li; Jiwei Fang
Journal:  Front Cell Dev Biol       Date:  2022-02-10

7.  Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.

Authors:  Minna Piipponen; Pilvi Riihilä; Jaakko S Knuutila; Markku Kallajoki; Veli-Matti Kähäri; Liisa Nissinen
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

8.  Giant desmoplastic cutaneous squamous cell carcinoma of the gluteal region.

Authors:  Darko Katalinic; Antonio Juretic
Journal:  World J Surg Oncol       Date:  2017-07-04       Impact factor: 2.754

9.  Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma.

Authors:  Pegah Rahmati Nezhad; Pilvi Riihilä; Jaakko S Knuutila; Kristina Viiklepp; Sirkku Peltonen; Markku Kallajoki; Seppo Meri; Liisa Nissinen; Veli-Matti Kähäri
Journal:  Cancers (Basel)       Date:  2022-01-08       Impact factor: 6.639

10.  Anti-growth and pro-apoptotic effects of dasatinib on human oral cancer cells through multi-targeted mechanisms.

Authors:  Nam-Sook Park; Yu-Kyung Park; Anil Kumar Yadav; Young-Min Shin; David Bishop-Bailey; Jong-Soon Choi; Jong Wook Park; Byeong-Churl Jang
Journal:  J Cell Mol Med       Date:  2021-07-28       Impact factor: 5.310
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.